Atossa Genetics Research Development Over Time
| ATOS Stock | USD 4.99 0.35 6.55% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Atossa Genetics Performance and Atossa Genetics Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will Atossa introduce new products? Factors like these will boost the valuation of Atossa Genetics. If investors know Atossa will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Atossa Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Atossa Genetics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Atossa Genetics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Atossa Genetics' market price to deviate significantly from intrinsic value.
Understanding that Atossa Genetics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Atossa Genetics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Atossa Genetics' market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Research Development Analysis
Compare Atossa Genetics and related stocks such as Oncolytics Biotech, Tevogen Bio Holdings, and Greenwich Lifesciences Research Development Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCY | 486.7 K | 23.4 M | 31.4 M | 18.5 M | 13.8 M | 8.6 M | 9.8 M | 9.4 M | 9.4 M | 11.1 M | 9.7 M | 10.3 M | 11.9 M | 13.1 M | 21.6 M | 24.9 M | 12.5 M |
| TVGN | 3 M | 3 M | 3 M | 3 M | 3 M | 3 M | 3 M | 3 M | 3 M | 3 M | 3 M | 3 M | 5.8 M | 4.4 M | 31 M | 35.7 M | 37.5 M |
| GLSI | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.3 M | 2.6 M | 1.1 M | 3.6 M | 6.5 M | 7.7 M | 13 M | 14.9 M | 15.6 M |
| TIL | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 19.4 M | 107.3 M | 141.1 M | 39.6 M | 11.8 M | 13.6 M | 12.9 M |
| IMMX | 583.2 K | 583.2 K | 583.2 K | 583.2 K | 583.2 K | 583.2 K | 583.2 K | 583.2 K | 583.2 K | 583.2 K | 248.1 K | 126.5 K | 4.2 M | 8.7 M | 11.3 M | 13 M | 13.6 M |
| WHWK | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 15 M | 19.7 M | 32.7 M | 48.9 M | 51 M | 58.7 M | 32.7 M |
| CLNN | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 8.8 M | 15.2 M | 28.4 M | 31.9 M | 26.7 M | 20.1 M | 23.1 M | 21.6 M |
| SRZN | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 25.7 M | 40.2 M | 37 M | 27.2 M | 21.1 M | 24.3 M | 31.3 M |
| CGTX | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 12.9 M | 18.6 M | 30.3 M | 37.2 M | 41.7 M | 47.9 M | 28.4 M |
| COYA | 373.5 K | 373.5 K | 373.5 K | 373.5 K | 373.5 K | 373.5 K | 373.5 K | 373.5 K | 373.5 K | 373.5 K | 373.5 K | 2.5 M | 4.9 M | 6 M | 11.9 M | 13.7 M | 14.4 M |
Atossa Genetics and related stocks such as Oncolytics Biotech, Tevogen Bio Holdings, and Greenwich Lifesciences Research Development description
My Equities
My Current Equities and Potential Positions
| Atossa Genetics | ATOS |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 107 Spring Street, |
| Exchange | NASDAQ Exchange |
USD 4.99
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.